2022
-
Marc Gurwith, MD, JD: A Double-Blind Ascending Dose Placebo-Controlled Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia
Marc Gurwith, MD, JD, will discuss the poster “A Double-Blind Ascending Dose Placebo-Controlled Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia” in a Sunday morning Ignite Talk.
-
Cristiana Sieiro Santos, MD: Immune Responses to mRNA Vaccines Against SARS-CoV-2 in Patients with Immune-mediated Inflammatory Rheumatic Diseases
Cristiana Sieiro Santos, MD, will discuss the poster “Immune Responses to mRNA Vaccines Against SARS-CoV-2 in Patients with Immune-mediated Inflammatory Rheumatic Diseases” in a Sunday afternoon Ignite Talk.
-
Lori Tucker, MD, FRCPC: A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
Lori Tucker, MD, FRCPC, will discuss the poster “A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)” in a Sunday afternoon Ignite Talk.
-
Catherine April Bingham, MD: Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis
Catherine April Bingham, MD, will discuss the poster “Radiographic Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis” in a Sunday afternoon Ignite Talk.
-
Distinguished Lecture: Advocacy is easier than you think
Rheumatology professionals routinely advocate on multiple levels, but they may not think of it as advocacy. In this year’s Distinguished Lecture, Kamala Nola, PharmD, MS, FAPhA, will discuss how providers can and do advocate for their patients through everyday actions, as well as how to…
-
RRF Lecture to focus on ACR guideline to individualize RA treatment
Michelle Ormseth, MD, MSCI, will deliver the Rheumatology Research Foundation Memorial Lecture to Honor William R. Palmer, MD, MACR. Using the ACR’s Continuing Assessment Review Evaluation (CARE) framework, she will review the newest advances in treating one of the most common autoimmune diseases.
-
Hench lecturer to examine the complexities of the heterogeneity of scleroderma
In this year’s Philip S. Hench, MD, Memorial Lecture, featured speaker Fredrick M. Wigley, MD, will discuss the growing understanding of scleroderma. “The clinician needs to appreciate both the subtype of scleroderma and the stage the patient is in to better define what would be…
-
Session to review changes in rheumatology spurred by COVID-19
Rheumatologists worldwide have risen to meet the challenges to the delivery of care created by the COVID-19 pandemic, said Minna Kohler, MD, RhMSUS. She will moderate a session on lessons learned beyond the disruption of this public health crisis.
-
No one-size-fits-all solution to osteoporosis treatment
Osteoporosis management decisions are influenced by a host of individual patient factors, including clinical risk, medical history, risk of falls, and activity levels. Sonali Khandelwal, MD, will discuss different medications used to treat this disease in a session on sequential therapy and lifelong maintenance.
-
Annual Year in Review to cover cutting-edge research in pediatric rheumatology
Mary Beth Son, MD, and Shaun Jackson, MD, PhD, will present a summary of the highlights of basic, translational, and clinical research published in the past year related to young rheumatology patients. The session includes recognition of pediatric award honorees.